RE:RE:Equity raise or LoCThe only problem Ulacin is that the current LoC only takes Lmnl till the end of September based on current cash burn. So the LoC would have to be increased significantly to get to FDA approval. Provided the BLA is filed soon, there is a chance that Lmnl could close a marketing deal shortly thereafter which could provide upfront money as well as an order to support commercial launch. Such a deal could create enough investor confidence to support an equity issue on Nasdaq. Who knows but what is shameful is that the company has taken so long to address CMC issues and refile the BLA and now the company finds itself in its traditional situation of running on fumes and on the cusp of total ruin. But hey the sp is up today so perhaps we are missing something.